• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Is Total Risk Management an Answer for Better Prognosis in Diabetic Patients?全面风险管理是改善糖尿病患者预后的答案吗？
J Atheroscler Thromb. 2016 Aug 1;23(8):903-4. doi: 10.5551/jat.ED050. Epub 2016 May 25.
2
Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome.全面风险管理对急性冠状动脉综合征糖尿病患者冠状动脉斑块消退的影响。
J Atheroscler Thromb. 2016 Aug 1;23(8):922-31. doi: 10.5551/jat.31948. Epub 2016 Mar 8.
3
Requiem for the 'vulnerable plaque'.“易损斑块”的挽歌
Eur Heart J. 2015 Nov 14;36(43):2984-7. doi: 10.1093/eurheartj/ehv349. Epub 2015 Jul 22.
4
[Stabilization of vulnerable coronary plaque].[易损冠状动脉斑块的稳定]
Nihon Rinsho. 2011 Nov;69 Suppl 9:306-10.
5
Qualitative plaque stabilization but not quantitative plaque regression.定性斑块稳定而非定量斑块消退。
Circ J. 2012;76(4):809-11. doi: 10.1253/circj.cj-12-0288.
6
[Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].[日本匹伐他汀与阿托伐他汀在急性冠状动脉综合征中的评估（JAPAN-aCS）研究]
Nihon Rinsho. 2011 Nov;69 Suppl 9:336-40.
7
[Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
Nihon Rinsho. 2011 Nov;69 Suppl 9:321-30.
8
More intensive lipid lowering is associated with regression of coronary atherosclerosis in diabetic patients with acute coronary syndrome--sub-analysis of JAPAN-ACS study.更强化的降脂治疗与急性冠脉综合征合并糖尿病患者冠状动脉粥样硬化的消退相关--JAPAN-ACS 研究的亚组分析。
J Atheroscler Thromb. 2010 Oct 27;17(10):1096-107. doi: 10.5551/jat.5660. Epub 2010 Jul 28.
9
The need to improve cardiac care after acute coronary syndrome.需要改善急性冠状动脉综合征后的心脏护理。
Hellenic J Cardiol. 2019 Jul-Aug;60(4):254-255. doi: 10.1016/j.hjc.2019.12.002.
10
Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.急性冠脉综合征后循环基质金属蛋白酶水平与冠脉斑块消退的相关性--JAPAN-ACS 研究的亚组分析。
Atherosclerosis. 2013 Jan;226(1):275-80. doi: 10.1016/j.atherosclerosis.2012.10.063. Epub 2012 Nov 2.

本文引用的文献

1
Impact of Total Risk Management on Coronary Plaque Regression in Diabetic Patients with Acute Coronary Syndrome.全面风险管理对急性冠状动脉综合征糖尿病患者冠状动脉斑块消退的影响。
J Atheroscler Thromb. 2016 Aug 1;23(8):922-31. doi: 10.5551/jat.31948. Epub 2016 Mar 8.
2
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.依泽替米贝/辛伐他汀降低急性冠脉综合征后的心血管复合终点事件：IMPROVE-IT 试验。
J Am Coll Cardiol. 2016 Feb 2;67(4):353-361. doi: 10.1016/j.jacc.2015.10.077.
3
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.恩格列净：在 2 型糖尿病中的心血管结局和死亡率。
N Engl J Med. 2015 Nov 26;373(22):2117-28. doi: 10.1056/NEJMoa1504720. Epub 2015 Sep 17.
4
Impact of type 2 diabetes on serial changes in tissue characteristics of coronary plaques: an integrated backscatter intravascular ultrasound analysis.2 型糖尿病对冠状动脉斑块组织特征的连续变化的影响：背向散射积分血管内超声分析。
Eur Heart J Cardiovasc Imaging. 2012 Sep;13(9):717-23. doi: 10.1093/ehjci/jes033. Epub 2012 Feb 24.
5
Oral pharmacologic treatment of type 2 diabetes mellitus: a clinical practice guideline from the American College of Physicians.《2 型糖尿病的口服药物治疗：美国医师学会临床实践指南》。
Ann Intern Med. 2012 Feb 7;156(3):218-31. doi: 10.7326/0003-4819-156-3-201202070-00011.
6
Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).糖尿病是急性冠状动脉综合征患者他汀类药物治疗期间冠状动脉斑块消退的主要负性决定因素——来自日本急性冠状动脉综合征中匹伐他汀和阿托伐他汀评估研究（JAPAN-ACS 试验）的系列血管内超声观察。
Circ J. 2010 Jun;74(6):1165-74. doi: 10.1253/circj.cj-09-0766. Epub 2010 May 12.
7
Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).强化他汀治疗对急性冠脉综合征患者冠状动脉粥样硬化消退的影响：一项使用匹伐他汀与阿托伐他汀通过血管内超声容积分析评估的多中心随机试验（日本急性冠脉综合征中匹伐他汀与阿托伐他汀评估研究[JAPAN-ACS]）
J Am Coll Cardiol. 2009 Jul 21;54(4):293-302. doi: 10.1016/j.jacc.2009.04.033.
8
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study.糖尿病患者与非糖尿病患者中男性和女性年龄与心血管疾病的关系：一项基于人群的回顾性队列研究。
Lancet. 2006 Jul 1;368(9529):29-36. doi: 10.1016/S0140-6736(06)68967-8.
9
Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.阿托伐他汀在2型糖尿病中对心血管疾病的一级预防：合作阿托伐他汀糖尿病研究（CARDS）：多中心随机安慰剂对照试验
Lancet. 2004;364(9435):685-96. doi: 10.1016/S0140-6736(04)16895-5.
10
Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.急性心肌梗死后左心室功能不全的糖尿病患者中，血管紧张素转换酶抑制剂群多普利对死亡率和发病率的影响。TRACE研究组
J Am Coll Cardiol. 1999 Jul;34(1):83-9. doi: 10.1016/s0735-1097(99)00146-1.

Is Total Risk Management an Answer for Better Prognosis in Diabetic Patients?

作者信息

Sakakura Kenichi

机构信息

Division of Cardiovascular Medicine, Saitama Medical Center, Jichi Medical University.

出版信息

J Atheroscler Thromb. 2016 Aug 1;23(8):903-4. doi: 10.5551/jat.ED050. Epub 2016 May 25.

DOI:10.5551/jat.ED050
PMID:27237103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7399294/
Abstract
摘要